|
Before founding GMI, Mrs. King was an Executive in Residence at New Enterprise Associates (NEA), a major venture capital firm with investments in biotechnology. Prior to joining NEA, Mrs. King was a Senior Vice President of Novartis Corporation. Before joining Novartis, Mrs. King spent ten years with Genetic Therapy, Inc. (GTI) from the company's startup phase, through its IPO and later acquisition by Novartis. At GTI, she held various roles, including serving as the company's CEO. Mrs. King also worked previously at ALZA Corporation in Palo Alto, California and at Bain and Company in Boston. She received her B.A degree from Dartmouth College and her MBA from Harvard Business School. Mrs. King currently serves on the Boards of Directors of MDBio and of the Biotechnology Industry Association (BIO). She also serves on the Dean's Council of the Harvard School of Public Health and is on the Board of Visitors of the University of Maryland Biotechnology Institute. | 